Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Non-Current Assets (2016 - 2025)

Palisade Bio (PALI) has disclosed Non-Current Assets for 16 consecutive years, with $145000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Non-Current Assets fell 68.88% to $145000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $1.1 million, a 55.86% decrease, with the full-year FY2024 number at $386000.0, down 46.69% from a year prior.
  • Non-Current Assets was $145000.0 for Q3 2025 at Palisade Bio, down from $220000.0 in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $1.1 million in Q3 2022 to a low of $92000.0 in Q1 2022.
  • A 5-year average of $514518.0 and a median of $428500.0 in 2022 define the central range for Non-Current Assets.
  • Peak YoY movement for Non-Current Assets: tumbled 82.23% in 2021, then soared 935.87% in 2023.
  • Palisade Bio's Non-Current Assets stood at $182000.0 in 2021, then skyrocketed by 465.93% to $1.0 million in 2022, then decreased by 29.71% to $724000.0 in 2023, then tumbled by 46.69% to $386000.0 in 2024, then plummeted by 62.44% to $145000.0 in 2025.
  • Per Business Quant, the three most recent readings for PALI's Non-Current Assets are $145000.0 (Q3 2025), $220000.0 (Q2 2025), and $303000.0 (Q1 2025).